“Obtaining equitable access to critical medicines needs a coherent health system reaction backed by robust political will, multisectoral cooperation, and people-centred programmes that depart no one at the rear of.”Significant price ranges of medicines like semaglutide and tirzepatide are restricting usage of these medicines. Prioritizing those